Transcranial Photobiomodulation (tPBM / Intranasal NIR) — Cognitive Technologies & Brain Longevity
Near-infrared and red light applied transcranially or intranasally to stimulate cytochrome c oxidase in brain mitochondria — studied for Alzheimer's, Parkinson's, TBI, and cognitive enhancement.
Overview
Transcranial photobiomodulation (tPBM) applies near-infrared light (600-1100 nm, primarily 810 nm and 1064 nm) transcranially to the brain, where photons penetrate the skull and stimulate cytochrome c oxidase (Complex IV) in neuronal mitochondria, increasing ATP production, reducing oxidative stress, and modulating neuroprotective signaling pathways. The primary chromophore is cytochrome c oxidase's copper centers, which absorb NIR light and accelerate electron transport. Vielight has commercialized intranasal and transcranial NIR devices (Vielight 810 Intranasal, Neuro Alpha/Gamma) for consumer use. A pilot RCT (2017, Photobiomodulation journal, n=11) found Vielight Neuro gamma (40 Hz pulsed, 810 nm) improved dementia symptoms over 12 weeks. A 2020 pilot RCT (n=8) with 1064 nm tPBM over prefrontal cortex significantly improved working memory and attention in healthy young adults. The NERI trial (New England Research Institutes) is conducting a larger RCT for mild Alzheimer's. Intranasal NIR targets the nasal mucosa vasculature, from which photons travel along nasal passages to the prefrontal cortex and olfactory bulb — providing a unique penetration pathway.
Indications
- Alzheimer's disease and MCI (pilot RCT evidence)
- Parkinson's disease (small trials and case reports)
- Traumatic brain injury (TBI) recovery
- Cognitive enhancement in healthy adults (prefrontal working memory)
- Depression (emerging trials)
Mechanism of Action
NIR light photons are absorbed by the copper centers (CuA, CuB) and heme groups of cytochrome c oxidase in mitochondria, increasing electron transfer rate, proton gradient, and ATP synthesis — effectively turbocharging mitochondrial energy production
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Vielight 810 Intranasal | 25 mW, 810 nm, pulse 10 Hz or continuous | 20-25 minutes/day, 6 days on, 1 day off | ~$350; intranasal targets prefrontal cortex and olfactory bulb via nasal mucosal vasculature |
| Vielight Neuro Alpha (transcranial) | 10 Hz pulsed, 810 nm, 5 transcranial nodes + intranasal | 20 minutes every other day | ~$1,749; covers multiple cortical regions including prefrontal, temporal, parietal; used in dementia pilot trials |
Evidence Grade
GRADE C
Safety & Contraindications
- Generally very safe: no serious adverse events in published tPBM trials
- Do not use high-powered laser devices near eyes — use devices with appropriate wavelength and power density
- Vielight consumer devices use non-coherent LEDs, not lasers — lower risk than laser-based clinical devices
- Avoid over-stimulation: excessive daily use may paradoxically reduce mitochondrial response (biphasic dose response)
- Headache, warmth, or mild tingling reported by minority of users — reduces dose if occurring